Recent News

• 08.04.2026 - Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical’s Replacement Venous Valve Therapy Compared to Standard of Care Treatments
• 07.31.2026 - enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
• 07.15.2026 - enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor “What This Means” Segment
• 07.07.2026 - enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
• 06.22.2026 - enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
• 06.02.2026 - enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
• 06.02.2026 - enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
• 05.12.2026 - enVVeno Medical Discusses FDA IDE Approval in Virtual Investor “What This Means” Segment
• 05.07.2026 - enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
• 04.29.2026 - enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve

Recent Filings

• 07.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.14.2026 - 8-K Current report
• 07.14.2026 - EX-99.1 EX-99.1
• 06.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2026 - 144 Report of proposed sale of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.29.2026 - 8-K Current report
• 04.29.2026 - EX-99.1 EX-99.1